Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities

(Neutral)

Rhea-AI Summary

Oculis (NASDAQ: OCS) announced the publication of notifications related to the vesting and settlement of previously granted restricted stock units (RSUs) awarded to company directors. The notifications concern RSU vests dated August 13, 2026, for directors Anthony Rosenberg, Christina Ackermann, Arshad Khanani and Robert Warner.

Market Context

The platform history shows four aligned outcomes and one divergence across recent Oculis news. The a...

Analysis

The platform history shows four aligned outcomes and one divergence across recent Oculis news. The active F-3 is an ineffective resale registration with zero usage, while insider activity is absent; future filings remain the relevant monitor.

Key Figures

Publication date: August 14, 2026 RSU vest date: 13 August 2026

2 metrics

Publication date August 14, 2026 Article dateline

RSU vest date 13 August 2026 Director RSU vesting notifications

Historical Context

5 past events · Latest: Aug 10 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 10	Asset purchase agreement	Positive	+0.6%	Asset purchase agreement added Privosegtor rights and removed prior licensing obligations.
Aug 06	Q2 earnings report	Positive	+2.4%	Reported Q2 results, cash runway into 2H 2029, and pipeline progress.
Aug 03	FDA development feedback	Positive	+5.1%	FDA feedback supported Privosegtor strategy and required no additional preclinical studies.
Jul 08	Manager transaction notice	Neutral	+0.0%	Notification covered a director's RSU vesting and settlement transaction dated July 5.
Jul 02	Conference participation	Neutral	+4.4%	Management scheduled discussion of late-stage Privosegtor and Licaminlimab programs at a virtual conference.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent Oculis news was followed by four aligned positive or flat outcomes and one divergence.

Key Terms

persons discharging managerial responsibilities, rsus

2 terms

persons discharging managerial responsibilities regulatory

"Notifications of Transactions by Persons Discharging Managerial Responsibilities"

Persons Discharging Managerial Responsibilities are the key people in a company who make big decisions, like top managers or executives. Knowing who they are is important because their actions can influence the company’s success or failure, and they are often required to share information about their dealings to ensure transparency for investors and the public.

rsus financial

"The attached notifications relate to the vesting and settlement of RSUs"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

08/14/2026 - 04:05 PM

ZUG, Switzerland, Aug. 14, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to the vesting and settlement of RSUs previously granted to directors of the Company.

Attachments

FAQ

What did Oculis (NASDAQ: OCS) announce on August 14, 2026 regarding director transactions?

Oculis announced it published notifications about the vesting and settlement of restricted stock units granted to its directors. According to Oculis, these notifications cover RSU vesting events that occurred on August 13, 2026, for four named board members.

Which Oculis (OCS) directors had RSU vesting transactions notified on August 14, 2026?

The notified RSU vesting transactions involved directors Anthony Rosenberg, Christina Ackermann, Arshad Khanani and Robert Warner. According to Oculis, the notifications relate to restricted stock units that vested and were settled on August 13, 2026, for these persons discharging managerial responsibilities.

What type of securities were involved in the Oculis (OCS) director notifications in August 2026?

The notifications concerned restricted stock units, or RSUs, previously granted to Oculis directors. According to Oculis, the August 14, 2026 disclosure covers the vesting and settlement of these RSUs for four directors following vest dates on August 13, 2026.

What is the effective date of the Oculis (OCS) RSU vesting for directors disclosed in August 2026?

The effective date for the RSU vesting events is August 13, 2026. According to Oculis, the company’s August 14, 2026 publication simply provides formal notifications of these vesting and settlement transactions for several directors serving as persons discharging managerial responsibilities.

Did Oculis (OCS) disclose financial figures with the August 14, 2026 director RSU notifications?

No specific financial figures or quantities of RSUs were disclosed in the announcement. According to Oculis, the release only states that notifications were published regarding the vesting and settlement of previously granted RSUs for four named directors on August 13, 2026.